ELITE PHARMA (SURREY) LIMITED

Active West Molesey

Wholesale of pharmaceutical goods

3 employees website.com
Wholesale of pharmaceutical goods
E

ELITE PHARMA (SURREY) LIMITED

Wholesale of pharmaceutical goods

Founded 1 Feb 2007 Active West Molesey, United Kingdom 3 employees website.com
Wholesale of pharmaceutical goods
Accounts Submitted 28 Oct 2025 Next due 31 May 2027 12 months remaining
Confirmation Submitted 6 Feb 2026 Next due 4 Feb 2027 8 months remaining
Net assets £23K £719 2025 year on year
Total assets £23K £110 2025 year on year
Total Liabilities £609
Charges 7
1 outstanding 6 satisfied

Contact & Details

Contact

Registered Address

Unit 2, Molesey Business Centre Central Avenue West Molesey Surrey KT8 2QZ United Kingdom

Full company profile for ELITE PHARMA (SURREY) LIMITED (06077954), an active company based in West Molesey, United Kingdom. Incorporated 1 Feb 2007. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Sept → 31 Aug 2025
Type micro-entity
Next accounts 31 Aug 2026
Due by 31 May 2027 12 months remaining

Balance Sheet & P&L (2014–2025)

Cash in Bank

N/A

Net Assets

£22.61k

Decreased by £719.00 (-3%)

Total Liabilities

£609.00

Turnover

N/A

Employees

3

Debt Ratio

3%

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Aug Year End
2024
30 Nov Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Ramesh Vasudev PatelDirectorBritishUnited Kingdom791 Feb 2007Active

Shareholders

Shareholders (3)

Kiritkumar Meghji Shah
58.3%
Ashok Kumar Dahyabhai Patel
20.8%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Mr Kiritkumar Meghji Shah

British

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB June 1956
Nature of Control
  • Ownership Of Shares 50 To 75 Percent
  • Voting Rights 50 To 75 Percent
  • Right To Appoint And Remove Directors

Ashokkumar Dahyabhai Patel

Ceased 13 May 2019

Ceased

Ramesh Vasudev Patel

Ceased 13 May 2019

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding 6 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
6 Feb 2026Confirmation StatementConfirmation statement made on 21 Jan 2026 with no updates
28 Oct 2025AccountsAnnual accounts made up to 31 Aug 2025
30 Aug 2025AccountsAnnual accounts made up to 30 Nov 2024
18 Aug 2025AccountsAnnual accounts made up to 30 Nov 2025
6 Feb 2025Confirmation StatementConfirmation statement made on 21 Jan 2025 with no updates
6 Feb 2026 Confirmation Statement

Confirmation statement made on 21 Jan 2026 with no updates

28 Oct 2025 Accounts

Annual accounts made up to 31 Aug 2025

30 Aug 2025 Accounts

Annual accounts made up to 30 Nov 2024

18 Aug 2025 Accounts

Annual accounts made up to 30 Nov 2025

6 Feb 2025 Confirmation Statement

Confirmation statement made on 21 Jan 2025 with no updates

Recent Activity

Latest Activity

Confirmation statement made on 21 Jan 2026 with no updates

3 months ago on 6 Feb 2026

Annual accounts made up to 31 Aug 2025

6 months ago on 28 Oct 2025

Annual accounts made up to 30 Nov 2024

8 months ago on 30 Aug 2025

Annual accounts made up to 30 Nov 2025

9 months ago on 18 Aug 2025

Confirmation statement made on 21 Jan 2025 with no updates

1 years ago on 6 Feb 2025